ARCHIMED completes acquisition of dental implant company ZimVie Oct 20, 2025 09:02AM
ZimVie stockholders approve ARCHIMED acquisition Oct 10, 2025 09:15AM
B.Riley Downgrades ZimVie Inc. (ZIMV) to Neutral Jul 31, 2025 03:41AM
ZimVie Inc. (ZIMV) Tops Q2 EPS by 3c Jul 30, 2025 06:10PM
ZimVie partners with Osstem Implant for China distribution deal Jul 23, 2025 04:06PM


Jul 22, 2025 09:44AM Barclays Upgrades ZimVie Inc. (ZIMV) to Equalweight
Jul 21, 2025 08:01AM ARCHIMED to acquire ZimVie for $19 per share in $730 million deal
May 15, 2025 09:49AM ZimVie Inc. (ZIMV) PT Lowered to $10 at UBS
May 9, 2025 06:46AM Needham Reiterates Hold Rating on ZimVie Inc. (ZIMV)
May 8, 2025 07:16PM ZimVie Inc. (ZIMV) Tops Q1 EPS by 5c
Apr 10, 2025 02:50AM B.Riley Starts ZimVie Inc. (ZIMV) at Buy
Mar 13, 2025 04:16PM ZimVie Inc. (ZIMV) Announces Board Changes
Mar 13, 2025 06:13AM Needham Downgrades ZimVie Inc. (ZIMV) to Hold
Mar 13, 2025 06:13AM Needham Downgrades DENTSPLY SIRONA (XRAY) to Hold
Feb 26, 2025 04:53PM ZimVie Inc. (ZIMV) Tops Q4 EPS by 1c ; Offers Guidance
Aug 1, 2024 04:17PM ZimVie Inc. (ZIMV) Misses Q2 EPS by 4c
Jul 23, 2024 08:05AM ZimVie Inc. (ZIMV) Announces FDA Clearance and U.S. Launch of GenTek Restorative Components
Jul 18, 2024 08:03AM ZimVie (ZIMV) is in Advanced Talks to be Acquired by Osstem Implant - Bloomberg
Jun 26, 2024 03:57AM ZimVie Inc. (ZIMV) call put ratio 6.5 calls to 1 put with a focus on July 15 and 20 calls
Jun 25, 2024 02:04PM ZimVie (ZIMV) could be worth $25-29 per share in a potential acquisition - Needham & Company
Jun 25, 2024 12:59PM ZimVie (ZIMV) reiterated at Buy by Needham on takeover rumors, 'ZIMV could be worth $25-29 per share'
Jun 25, 2024 11:11AM ZimVie (ZIMV) Said To Weigh Options Including Potential Sale - Bloomberg